Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

计划入组 1,065 人 · 首次发布于 2005 年 9 月 15 日

Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy

计划入组 602 人 · 首次发布于 2002 年 11 月 20 日

Potassium Citrate to Prevent Age Related Bone Loss

计划入组 52 人 · 首次发布于 2006 年 1 月 25 日

Bone Cancer(Diakonos)

APD-310

LGR4 modulators (cancer/bone disorders)

Si-Bone

United States

Bone Biologics

Bone Therapeutics

Belgium

Samsung Bioepis Receives Positive CHMP Opinion for Denosumab Biosimilars OBODENCE and XBRYK

Abbott Secures First Denosumab Biosimilar Approval in Thailand, Expanding Access to Bone Disease Treatment

NICE Recommends Pedmarqsi as First NHS Treatment for Cisplatin-Induced Hearing Loss in Children